Oruka Therapeutics (ORKA) Stock Forecast: StockMap's 2-Week Call

ORKA stock forecast: StockMap's model leans Outperform on Oruka Therapeutics for the two weeks after the Nov 19 close, toward ORKA doing better than the growth index. It is a lean inside the no-call band, not a call, and not a price target. Too few two-week windows graded to judge yet.

Oruka Therapeutics last closed at $97.57, +1.91% on the session.

Against the IVW growth benchmark the position is +4.24% over the forecast window.

Oruka Therapeutics' market cap is $6.62B as of November 19, 2026.

Leans up ↗: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 24 (too close to call).

Where ORKA sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 10 bullish and 5 bearish.

Agreement across those insights is 67%.

8 daily calls for ORKA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Oruka Therapeutics in the 27th percentile on return on equity, where 100 is best.

Oruka Therapeutics is classified under Health Care / Biotechnology.

StockMap tracks Oruka Therapeutics as the 41st largest of the 394 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 200 Moderate Underperform, 134 Neutral, 43 Strong Underperform and 17 Moderate Outperform.

On that composite Oruka Therapeutics ranks 12th of 394 in the group, against a group median of -0.27.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 19, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

Oruka Therapeutics (ORKA) — StockMap 2-week forecast & tracked accuracy